-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX PHARMACEUTICALS (NASDAQ:NRXP) RECEIVES FDA APPROVAL OF PRESERVATIVE-FREE KETAMINE AHEAD OF NOVEMBER 10 FDA GOAL DATE

Reuters·10/30/2026 11:00:02

Please log in to view news